Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Inhibition of recombinant human ALK2 (147 to end residues) expressed in Sf9 infected baculovirus expression system using TRF0130 as substrate incubated for 3 hrs in presence of APT
Assay data:2 Active, 2 Activity ≤ 1 µM, 2 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Inhibition of human ALK2 by NanoBERT assay
Assay data:5 Tested
SummaryPubMed CitationRelated BioAssays by Target
Inhibition of ALK2 (unknown origin)
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
Assay data:1 Tested
ALK2 HTRF Assay from US Patent US11840546: "Imidazopyridazine compounds and uses thereof"
Assay data:4 Active, 4 Activity ≤ 1 nM, 4 Activity ≤ 1 µM, 4 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
In Vitro Enzymatic Activity Inhibition Test (TGFbetaR1) from US Patent US20230303562: "PYRAZOLE COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF"
Assay data:11 Active, 1 Activity ≤ 1 nM, 11 Activity ≤ 1 µM, 11 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Target
LanthaScreen Eu Kinase Binding Assay from US Patent US11746103: "ALK-5 inhibitors and uses thereof"
Assay data:8 Active, 56 Activity ≤ 1 µM, 56 Tested
In Vitro Kinase Assay - Inhibition of ALK1/2/3/4/5/6 Kinases from US Patent US11702401: "Compounds and methods of use"
Assay data:33 Active, 32 Activity ≤ 1 µM, 36 Tested
Biochemical assay from US Patent US11661426: "Imidazole-containing inhibitors of ALK2 kinase"
Assay data:455 Active, 496 Activity ≤ 1 µM, 496 Tested
Luciferase Reporter Gene Assay for ALK2 and TGFbeta Activity from US Patent US11654147: "ALK2 inhibitors and methods for inhibiting BMP signaling"
Assay data:149 Active, 1 Activity ≤ 1 nM, 165 Activity ≤ 1 µM, 170 Tested
Selectivity interaction (KinomeScan (DiscoverX, competition-binding assay)) EUB0000207b ACVR1
Inhibition of ALK-2 (unknown origin)
Inhibition of ALK2 in human HeLa cells assessed as inhibition of SMAD1 phosphorylation
Assay data:12 Active, 9 Activity ≤ 1 µM, 14 Tested
Assay data:28 Active, 26 Activity ≤ 1 µM, 28 Tested
Inhibition of human recombinant ALK2 (172 to 499 residues) expressed in baculovirus-infected insect cells by ADP-Glo kinase assay
Inhibition of GST-tagged human recombinant ALK2 (145 to 509 residues) expressed in baculovirus expression system using casein as substrate in presence of [gamma-32P]ATP incubated for 45 mins by Microscint-20 scintillation counting analysis
Inhibition of ALK2 in human HeLa cells assessed as reduction in BMP-7 induced SMAD1 phosphorylation incubated for 1 hr followed BMP-7 stimulation for 30 mins by HTRF assay
Assay data:11 Active, 11 Activity ≤ 1 µM, 12 Tested
Inhibition of human recombinant N-terminal GST tagged ALK2 (147 to end residues) expressed in baculovirus infected in Sf9 cells assessed as loss of peptide phosphorylation activity using peptide substrate in presence of ATP and measured after 3 hrs by HTRF assay
Assay data:16 Active, 2 Activity ≤ 1 nM, 16 Activity ≤ 1 µM, 16 Tested
Binding affinity to wild type ALK2 (unknown origin) assessed as percent of control at 1 uM by Kinomescan method relative to control
Inhibition of wild type ALK2 (unknown origin) assessed as enzymatic activity by microfluidic mobility shift assay
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on